D. E. Shaw & Co., Inc. Laboratory Corp Of America Holdings Put Options Transaction History

D. E. Shaw & Co., Inc.

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $7.35 Million - $8.46 Million	37,200 Added 338.18%	48,200 $11 Million
Q3 2023 Nov 14, 2023	SELL	$201.05 - $221.7 $8.87 Million - $9.78 Million	-44,100 Reduced 80.04%	11,000 $2.21 Million
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $7.23 Million - $8.23 Million	34,100 Added 162.38%	55,100 $13.3 Million
Q1 2023 May 15, 2023	SELL	$213.32 - $257.83 $2.13 Million - $2.58 Million	-10,000 Reduced 32.26%	21,000 $4.82 Million
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $4.07 Million - $4.98 Million	20,000 Added 181.82%	31,000 $7.3 Million
Q3 2022 Nov 14, 2022	BUY	$204.81 - $262.19 $2.25 Million - $2.88 Million	11,000 New	11,000 $2.25 Million
Q3 2020 Nov 16, 2020	SELL	$167.03 - $201.3 $1.67 Million - $2.01 Million	-10,000 Reduced 42.55%	13,500 $2.54 Million
Q2 2020 Aug 14, 2020	BUY	$113.31 - $182.44 $1.53 Million - $2.46 Million	13,500 Added 135.0%	23,500 $3.9 Million
Q1 2020 May 15, 2020	BUY	$104.32 - $195.28 $1.04 Million - $1.95 Million	10,000 New	10,000 $1.26 Million

126

2.48M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $19.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.